Article
Clopidogrel dose adjustment after outpatient screening for CYP2C19 variant alleles: a pilot study.
Pharmacogenomics - 1 May 2014
Rossi Joseph S, Cammarata Michael, Dharmavaram Jayalalitha, Weck Karen, Walko Christine, Gabriel Don, Kuritzky Jack, Muldrew Kenneth, Stouffer George A
Abstract excerpt
This pilot study examined the feasibility of outpatient screening and clopidogrel dose adjustment for patients with previous percutaneous coronary intervention and at least one CYP2C19 loss-of-function allele. After screening a total of 211 outpatients, 50 patients were enrolled in a crossover study comparing 30 days of standard dose (75 mg) to 30 days of high-dose clopidogrel (150 mg). Platelet function was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
